Status not kept up to date
Robotic Versus Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer
NCT03273920 · Southwest Hospital, China · Updated 8 Sept 2017
- What is being tested
- Robotic distal gastrectomy with D2 nodal dissection; Laparoscopic distal gastrectomy with D2 nodal dissection
- For
- Gastric Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 20 years to 75 years. About 1,110 people. The full rules are on the registry page.
- Where
- China (14 sites)
- When
- Starts or started 25 Sept 2017, ends 25 Sept 2022. Registered 6 Sept 2017.
- Results
- None posted yet.
In the researchers' words
This study is an investigator-initiated, randomized, controlled, parallel group, and non-inferiority trial comparing robot-assisted gastrectomy with D2 nodal dissection for locally advanced gastric cancer patients with laparoscopic procedure.
Sites
- Chinese PLA general hospitalBeijing, Beijing Municipality, China
- Peking University Cancer HospitalBeijing, Beijing Municipality, China
- Department of General Surgery and Center of Microinvasive Gastrointestinal Surgery, Southwest HospitalChongqing, Chongqing Municipality, China
- Fujian Medical University Union HospitalFuzhou, Fujian, China
- Lanzhou PLA General HospitalLanzhou, Gansu, China
- Sun Yat-sen University Cancer CenterGuangzhou, Guangdong, China
- Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, Hubei, China
- The Second Xiangya Hospital of Central South UniversityChangsha, Hunan, China
- Nanjing General HospitalNanjing, Jiangsu, China
- The First Affiliated Hospital of Nanchang UniversityNanchang, Jiangxi, China
- Jilin Cancer HospitalChangchun, Jilin, China
- The Affiliated Hospital of Qingdao UniversityQingdao, Shandong, China
- Xijing Hospital of Digestive DieasesXi’an, Shanxi, China
- West China Hospital, Sichuan UniversityChengdu, Sichuan, China